Lifecanvas Technologies Inc.

Lifecanvas Technologies Inc., a woman-owned and minority-owned small disadvantaged business based in Cambridge, Massachusetts, manufactures and operates specialized bioimaging equipment and provides contract research organization services to federal research agencies as a prime contractor, with 97% of recent awards held as prime positions and performance occurring at its East Cambridge facility.

Lifecanvas specializes in high-resolution tissue imaging, tissue processing, and neural mapping technologies for neuroscience research. The company's product suite includes SMARTSPIM light sheet microscopy systems for whole-organ imaging, SMARTBATCH+ electrophoretic tissue clearing and immunolabeling devices, and the Megatome precision vibrating microtome for tissue sectioning. Recent representative purchase orders include a $344,950 delivery of a light sheet microscope system with specified laser lines to the National Institute of Neurological Disorders and Stroke for Parkinson's disease research (September 2024), a $134,880 contract with Veterans Integrated Service Network 20 for whole-organ tissue processing, SMARTSPIM imaging, and analysis services (July 2022), and a $38,208 purchase order from the National Institute on Alcohol Abuse and Alcoholism for tissue clearing, labeling, SMARTSPIM 3.6X imaging, and downstream analysis including Allen Brain Atlas registration and cell detection (September 2026). Work also includes contract research services — tissue clearing, immunolabeling, light sheet imaging of rodent brain samples, and quantitative cellular analysis — billed on a per-project basis at laboratories within NIH and the Department of Veterans Affairs.

Customer concentration is heavy within NIH and the VA. The top five funding agencies account for 81% of awards by count, led by the National Institute of Mental Health (seven awards, $44 thousand combined potential value) and Veterans Integrated Service Network 1 (six awards, $295 thousand combined potential value). When ranked by combined potential value, NINDS ($433 thousand across three awards) anchors the portfolio, followed by VISN 1 ($295 thousand) and Veterans Integrated Service Network 21 ($252 thousand). Lifecanvas also holds awards from the National Institute of Child Health and Human Development, the National Institute on Alcohol Abuse and Alcoholism, the National Institute of Neurological Disorders and Stroke, the National Institute of Allergy and Infectious Diseases, and the Department of Veterans Affairs across multiple service networks.

Lifecanvas operates primarily as a purchase-order vendor with no participation in government-wide IDIQs, GWACs, or larger contract vehicles. Awards are standalone competitive or sole-source purchase orders, reflecting the specialized and often unique nature of the company's offerings. The company holds a single federal grant award as prime recipient: a National Institute of Mental Health project grant (CFDA 93.242) awarded June 2023 for high-throughput 3D mapping of large mammalian brains via integration of precision tissue sectioning and light sheet imaging, with performance through May 2025. Lifecanvas also serves as sub-recipient on an MIT-led grant from NIMH (as of September 2025) to develop a pipeline for processing and imaging cell-type markers in whole human brain hemispheres.

Activity shows mixed trajectory. Awards per year held steady at five to six annually from 2022 through 2024, declining to three awards in 2025 and two in 2026. Combined potential value across all 32 awards totals $1.5 million, though combined dollars obligated across all awards reach $8.9 million — reflecting the fact that many purchase orders have been obligated and delivered at or above their original ceiling values. Two awards face ultimate completion within the next twenty-four months, carrying combined potential value of $88 thousand and exposing modest recompete risk. Primary NAICS codes reflect the company's dual role as equipment manufacturer and testing services provider: Analytical Laboratory Instrument Manufacturing (18 awards) dominates, with Testing Laboratories and Services (5 awards) representing the contract research organization work. PSC alignment follows: Laboratory Equipment and Supplies (13 awards) and Reference Laboratory Testing (6 awards) account for the bulk of procurement classification.